Patient P-03437
Therapy response
Unstable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
59%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S12
- Day 31 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 31.
Primary contributors, last 14 days
- GI instability+29
- Inflammatory activity+17
- Nutritional resilience-15
- Treatment adherence-5
- Toxicity-2
What helped?
No interventions yet.
LIFE OS recommendation
Dosing / Timing Recommendation DT-01
60%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 79% showed improvement
- median effect visible after 5 days
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- Mucosal barrier integrity ↓40
- DNAFUT2 non-secretor lowers mucosal fucosylation
- WearableSleep 5.3 h, below personal baseline
- Autonomic recovery ↑40
- Wearable2,556 steps/day
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 54/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 66 ms
- Sleep
- 6.3 h
- Steps
- 2,738
- Resting HR
- 64 bpm
Daily log: GI score 39, nutritional resilience 58, adherence 78.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03235 | 35% | S13 | GI-04 | improved | 29 |
| P-03277 | 34% | S14 | BR-03 | improved | 41 |
| P-03424 | 32% | S12 | AD-05 | improved | 41 |
| P-03307 | 30% | S03 | ME-01 | improved | 17 |
| P-03426 | 30% | S18 | BR-03 | improved | 27 |
| P-03442 | 30% | S11 | DT-01 | improved | 51 |
| P-03114 | 29% | S11 | DT-01 | improved | 48 |
| P-03215 | 29% | S16 | HY-01 | improved | 44 |
| P-03268 | 29% | S15 | DT-01 | improved | 56 |
| P-03373 | 29% | S17 | BR-03 | improved | 34 |
| P-03380 | 29% | S16 | AD-05 | improved | 34 |
| P-03392 | 29% | S15 | GI-04 | improved | 52 |